CellaVision AB (STO:CEVI) reported its second-quarter 2025 results on July 18, showing organic growth of 7.6% despite facing significant currency headwinds. The company’s stock rose 1.44% to SEK 183.2 ...
CellaVision AB (STO:CEVI) presented its Q1 2025 results on April 29, showcasing strong performance across all regions despite a challenging market environment. The company’s stock has responded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results